Reduction in disease progression by inhibition of transforming growth factor α-CCL2 signaling in experimental posttraumatic osteoarthritis. - Appleton CT; Usmani SE; Pest MA; Pitelka V; Mort JS; Beier F (Arthritis & rheumatology (Hoboken, N.J.), 2015)